Back to Search
Start Over
High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma
- Source :
- Annals of Surgical Oncology; 22(7), pp 2431-2438 (2015), Annals of Surgical Oncology
- Publication Year :
- 2015
- Publisher :
- Springer, 2015.
-
Abstract
- Background Cathepsin E (CTSE), an aspartic proteinase, is differentially expressed in the metaplasia–dysplasia–neoplasia sequence of gastric and colon cancer. We evaluated CTSE in Barrett’s esophagus (BE) and cancer because increased CTSE levels are linked to improved survival in several cancers, and other cathepsins are up-regulated in BE and esophageal adenocarcinoma (EAC). Methods A total of 273 pretreatment tissues from 199 patients were analyzed [31 normal squamous esophagus (NE), 29 BE intestinal metaplasia, 31 BE with dysplasia (BE/D), 108 EAC]. CTSE relative mRNA expression was measured by real-time polymerase chain reaction, and protein expression was measured by immunohistochemistry. CTSE serum levels were determined by enzyme-linked immunosorbent assay. Results Median CTSE mRNA expression levels were ≥1,000-fold higher in BE/intestinal metaplasia and BE/D compared to NE. CTSE levels were significantly lower in EAC compared to BE/intestinal metaplasia and BE/D, but significantly higher than NE levels. A similar expression pattern was present in immunohistochemistry, with absent staining in NE, intense staining in intestinal metaplasia and dysplasia, and less intense EAC staining. CTSE serum analysis did not discriminate patient groups. In a uni- and multivariable Cox proportional hazards model, CTSE expression was not significantly associated with survival in patients with EAC, although CTSE expression above the 25th percentile was associated with a 41 % relative risk reduction for death (hazard ratio 0.59, 95 % confidence interval 0.27–1.26, p = 0.17). Conclusions CTSE mRNA expression is up-regulated more than any known gene in Barrett intestinal metaplasia and dysplasia tissues. Protein expression is similarly highly intense in intestinal metaplasia and dysplasia tissues. Electronic supplementary material The online version of this article (doi:10.1245/s10434-014-4155-y) contains supplementary material, which is available to authorized users.
- Subjects :
- Male
Pathology
Esophageal Neoplasms
Colorectal cancer
Cathepsin E
Immunoenzyme Techniques
0302 clinical medicine
Metaplasia
Translational Research and Biomarkers
0303 health sciences
Reverse Transcriptase Polymerase Chain Reaction
Middle Aged
Prognosis
3. Good health
Survival Rate
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Adenocarcinoma
Female
medicine.symptom
medicine.medical_specialty
Enzyme-Linked Immunosorbent Assay
Real-Time Polymerase Chain Reaction
Barrett Esophagus
03 medical and health sciences
Esophagus
Biomarkers, Tumor
medicine
Humans
RNA, Messenger
Aged
Neoplasm Staging
030304 developmental biology
Cathepsin
business.industry
Cancer
medicine.disease
digestive system diseases
Case-Control Studies
Barrett's esophagus
Cancer and Oncology
Surgery
business
Precancerous Conditions
Follow-Up Studies
Subjects
Details
- Language :
- English
- ISSN :
- 15344681
- Database :
- OpenAIRE
- Journal :
- Annals of Surgical Oncology; 22(7), pp 2431-2438 (2015), Annals of Surgical Oncology
- Accession number :
- edsair.doi.dedup.....e5cce520b2cc9f913a30cec98ed1166b